Department of Orthopaedics and Traumatology, The University of Hong Kong, Queen Mary Hospital, Hong Kong Special Administrative Region, Hong Kong, China.
PLoS One. 2022 Apr 29;17(4):e0267861. doi: 10.1371/journal.pone.0267861. eCollection 2022.
Midshaft clavicular fractures are common amongst young adults. Conservative or surgical treatment for definitive fracture management has been widely debate, both with their pros and cons. Previous meta-analyses compared the clinical outcomes between conservative and surgical treatment options of midshaft clavicular fractures but failed to elucidate any difference in functional improvement. We postulate that functional improvement after fracture union plateaus and the clinical outcome after treatment varies at different time points. This meta-analysis will focus on the synthesis comparison of outcomes at early, short-term results (3 months), intermediate-term (6 to 12 months) and long-term (>24 months) clinical outcomes.
A systematic search was done on databases (Pubmed, Embase, Medline, Cochrane) in June 2021. Search keywords were: midshaft clavicular fractures and clinical trials. Clinical trials fulfilling the inclusion criteria were selected for comparison and the clinical outcomes of midshaft clavicular fractures using surgical and non-surgical interventions in terms of improvement in the Disabilities of the Arm, Shoulder and Hand (DASH) score, Constant-Murley Score (CMS), time to union and risk ratio of treatment related complications were analysed in correlation with post-treatment timeframe.
Of the 3094 patients of mean age 36.7 years in the 31 selected studies, surgical intervention was associated with improved DASH score (standard-mean difference SMD -0.22, 95% CI -0.36 to -0.07, p = 0.003; mean difference MD -1.72, 95% CI -2.93 to -0.51, p = 0.005), CMS (SMD 0.44, 95% CI 0.17-0.72, p = 0.001; MD 3.64, 95% CI 1.09 to 6.19, p = 0.005), time to union (non-adjusted SMD -2.83, 95% CI -4.59 to -1.07, p = 0.002; adjusted SMD -0.69, 95% CI -0.97 to -0.41, p<0.001) and risk ratio of bone-related complications including bone non-union, malunion and implant failure (0.21, 95% CI 0.1 to 0.42; p<0.001). Subgroup analysis based on time period after treatment showed that surgical intervention was far superior in terms of improved DASH score at the intermediate-term results (6-12 months later, SMD -0.16, 95% CI -0.30 to -0.02, p = 0.02; and long term results (>24 months SMD -4.24, 95% CI -7.03 to -1.45, p = 0.003) and CMS (>24 months, SMD 1.03, 95% CI 0.39 to 1.68, p = 0.002; MD 5.77, 95% CI 1.63 to 9.91, p = 0.006). Surgical outcome is independent of fixation with plates or intra-medullary nails.
Surgical intervention was associated with better clinical outcomes compared with non-surgical approach for midshaft clavicular fractures in terms of improvement in functional scores DASH, CMS, time to union and fracture related complications, although not to the minimal clinically significant difference. Benefits in the long-term functional improvements are more pronounced.
锁骨中段骨折在年轻成年人中较为常见。对于明确骨折的治疗,保守治疗或手术治疗都有其优缺点,因此一直存在广泛的争论。先前的荟萃分析比较了保守和手术治疗锁骨中段骨折的临床结果,但未能阐明功能改善方面的任何差异。我们假设骨折愈合后功能改善趋于稳定,并且治疗后的临床结果在不同时间点有所不同。本荟萃分析将重点关注早期、短期(3 个月)、中期(6-12 个月)和长期(>24 个月)临床结果的结果综合比较。
2021 年 6 月,我们在数据库(PubMed、Embase、Medline、Cochrane)中进行了系统搜索。搜索关键词为:锁骨中段骨折和临床试验。选择符合纳入标准的临床试验进行比较,并分析使用手术和非手术干预治疗锁骨中段骨折的临床结果,包括手臂、肩部和手部残疾(DASH)评分、常数-穆雷评分(CMS)、愈合时间和与治疗相关并发症风险比的改善情况,与治疗后时间相关联。
在 31 项研究中,有 3094 名平均年龄为 36.7 岁的患者,手术干预与 DASH 评分改善相关(标准均数差 SMD -0.22,95%置信区间 -0.36 至 -0.07,p = 0.003;平均差 MD -1.72,95%置信区间 -2.93 至 -0.51,p = 0.005)、CMS(SMD 0.44,95%置信区间 0.17-0.72,p = 0.001;MD 3.64,95%置信区间 1.09 至 6.19,p = 0.005)、愈合时间(未调整 SMD -2.83,95%置信区间 -4.59 至 -1.07,p = 0.002;调整 SMD -0.69,95%置信区间 -0.97 至 -0.41,p<0.001)和与骨相关的并发症风险比,包括骨不愈合、畸形愈合和植入物失败(0.21,95%置信区间 0.1 至 0.42;p<0.001)。基于治疗后时间的亚组分析表明,手术干预在中期(6-12 个月后)DASH 评分改善方面明显优于非手术干预(SMD -0.16,95%置信区间 -0.30 至 -0.02,p = 0.02;和长期结果(>24 个月 SMD -4.24,95%置信区间 -7.03 至 -1.45,p = 0.003)和 CMS(>24 个月,SMD 1.03,95%置信区间 0.39 至 1.68,p = 0.002;MD 5.77,95%置信区间 1.63 至 9.91,p = 0.006)。手术结果与钢板或髓内钉固定无关。
与非手术治疗相比,手术干预在改善锁骨中段骨折的功能评分 DASH、CMS、愈合时间和骨折相关并发症方面具有更好的临床效果,尽管未达到最小临床显著差异。长期功能改善的益处更为明显。